Our clients include world's top universities and pharmaceutical organizations
Merck
Wednesday, October 23, 2024
CDC’S ACIP Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults 50 Years of Age and Older
Aprea Therapeutics
Wednesday, October 23, 2024
Aprea Therapeutics Presents Preliminary Findings on Oral WEE1 Inhibitor APR-1051 at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics
CymaBay Therapeutics
Tuesday, October 22, 2024
Gilead to Present Latest Research Across Key Liver Disease Indication at the American Association for the Study of Liver Disease (AASLD) Meeting 2024
Astellas Pharma
Monday, October 21, 2024
Astellas’ VYLOYTM (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced Gastric and GEJ Cancer
17th Clinical Trials on Alzheimer’s Disease conference (CTAD)
Tuesday, October 29, 2024
Madrid, Spain
Science
Thursday, October 17, 2024
Global rise in forest fire emissions linked to climate change in the extratropics
Science
Thursday, October 17, 2024
Mechanism of bacterial predation via ixotrophy
Science
Thursday, October 17, 2024
AI can help humans find common ground in democratic deliberation
Science
Thursday, October 17, 2024
Megastudy testing 25 treatments to reduce antidemocratic attitudes and partisan animosity
Harpoon Therapeutics
Saturday, October 19, 2024
GILEAD AND MERCK ANNOUNCE PHASE 2 DATA SHOWING A TREATMENT SWITCH TO AN INVESTIGATIONAL ORAL ONCE-WEEKLY COMBINATION REGIMEN OF ISLATRAVIR AND LENACAPAVIR MAINTAINED VIRAL SUPPRESSION IN ADULTS AT WEEK 48
Bayer
Saturday, October 19, 2024
This news release (German version) is protected by “DocCheck”
Gilead Sciences
Saturday, October 19, 2024
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression in Adults at Week 48
Regeneron Pharmaceuticals
Friday, October 18, 2024
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
Science
Wednesday, October 16, 2024
People consistently view elections and civil liberties as key components of democracy
Science
Wednesday, October 16, 2024
Variational benchmarks for quantum many-body problems
Science
Wednesday, October 16, 2024
Neurotoxic mixture effects of chemicals extracted from blood of pregnant women
Science
Wednesday, October 16, 2024
Multicore memristor from electrically readable nanoscopic racetracks
Editas Medicine
Friday, October 18, 2024
Editas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept
Phio Pharmaceuticals
Friday, October 18, 2024
Correction to Registration Link to Access Phio Pharmaceuticals’ Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Theravance Biopharma
Friday, October 18, 2024
Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease
Novartis
Friday, October 18, 2024
Novartis receives positive CHMP opinion for Kisqali® to help reduce risk of recurrence in people with HR+/HER2- early breast cancer
Science
Wednesday, October 16, 2024
Capacity recovery by transient voltage pulse in silicon-anode batteries
Science
Wednesday, October 16, 2024
Unexpected far-field deformation of the 2023 Kahramanmaraş earthquakes revealed by space geodesy
Science
Wednesday, October 16, 2024
Consumer biodiversity increases organic nutrient availability across aquatic and terrestrial ecosystems
Science
Wednesday, October 16, 2024
Description and functional validation of human enteroendocrine cell sensors
Arcutis Biotherapeutics
Friday, October 18, 2024
Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older
Phio Pharmaceuticals
Friday, October 18, 2024
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
REGENXBIO
Friday, October 18, 2024
REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
Can Fite Biopharma
Friday, October 18, 2024
Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
Nature
Tuesday, October 15, 2024
Circadian plasticity evolves through regulatory changes in a neuropeptide gene
Nature
Tuesday, October 15, 2024
Glucose-sensitive insulin with attenuation of hypoglycaemia
Nature
Tuesday, October 15, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin disease
Nature
Tuesday, October 15, 2024
Neuronal sequences in population bursts encode information in human cortex
494 494
513 513
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.